Skip to content

Study · Not a test of the peptide alone · 2002

1 result

ANTIMICROBIAL AMINO ACID SEQUENCES DERIVED FROM ALPHA-MELANOCYTE-STIMULATING HORMONE

CATANIA Anna Pia, LIPTON James M.

Journal not recorded17 Mar 2000

PepBankPUB-95839360
Source linkAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking KPV.

  1. 01LabNot a test of KPV aloneIn vitro (cells)Activity measurement

    Pooled alpha-MSH derived peptides, including KPV-containing sequences, had antimicrobial activity against Staphylococcus aureus and Candida albicans.

    In plain wordsIn lab tests, a group of alpha-MSH derived peptides, including some with the KPV sequence, acted against two microbes.

    Peptide
    KPV
    Outcome
    Not applicableAntimicrobial activity against S. aureus and C. albicans
    Study

    S. aureus; C. albicansn: not reported in source

    microbial culture
    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    It has been found that this peptide, and other peptides derived from a-MSH, possess antimicrobial activity against Staphylococcus aureus and Candida albicans.
    1 context sentence
    Summary · context
    Of particular interest are those peptides that include the amino acid sequence KPV, or those including the sequence MEHFRWG.

    In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking KPV.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:19 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:56 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.